Clinical Trial: Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional

Official Title: A Randomized, Double-Blind, Placebo-controlled, Efficacy, Safety, and Tolerability Study of Bifeprunox in the Treatment of Elderly Subjects With Psychosis and Behavioral Disturba

Brief Summary: This is a 10-week study with bifeprunox and placebo in elderly subjects with psychosis and behavioral disturbances associated with dementia of the alzheimer's type.

Detailed Summary:
Sponsor: Solvay Pharmaceuticals

Current Primary Outcome: Brief Psychiatric Rating Scale (BPRS) Total Score [ Time Frame: 10 weeks ]

Original Primary Outcome:

Current Secondary Outcome: Adverse events [ Time Frame: 10 weeks ]

Original Secondary Outcome:

Information By: Solvay Pharmaceuticals

Dates:
Date Received: September 8, 2005
Date Started: December 2005
Date Completion:
Last Updated: January 29, 2015
Last Verified: June 2009